NatiVita

en
  • Русский
  • English

Innovations
for Life

NatiVita is an international research and manufacturing company that develops and produces innovative medications for treatment of cancer and other serious diseases.
Learn more
Research
Production
Drugs

Drugs

NatiVita Company manufactures cancer treatment drugs; it also produces drugs for integrative therapy of rheumatologic, autoimmune and serious infectious diseases. NatiVita medications are prescription-only and may be administered by a treating doctor only.
More

Production

The NatiVita's state-of-the-art manufacturing complex provides for full-cycle medication production in strict compliance with the European GMP (Good Manufacturing Practice) standard. A special isolator-based technology provides for a high level of product quality, occupational and environmental safety.
More

Research

The NatiVita's R&D Center works on implementation of two wide-scale programs: development of monoclonal antibody-based medications (MABPOINT Program) and production of chemical generic drugs (CHEMMOTION Program). Our research interests include application of personalized targeted cancer therapy and production of efficient and safe medications.
More

Nativita in Numbers

30 INNOVATIVE MEDICATIONS

developed in the NatiVita Lab will be available to millions of people in the CIS, Baltics and Eastern Europe

9 RESEARCH PROGRAMS

for innovative medicines developing hold with NatiVita participation

EURO 8 MLN

was saved the Belarusian budget in 2016 thanks to the Nativita drugs

Our Team

People entrust their most precious asset to us – their health. Every day, we contribute maximum knowledge and efforts to our work, and keep pushing our boundaries. NatiVita is more than a team of the highest-class professionals. It is a team united around one goal – help people suffering from serious diseases. Operating by international business standards and applying state-of-the-art pharmaceutical manufacturing technology, NatiVita offers its employees an opportunity to gain unique experience in the field of pharmaceutics and biotechnology.
Learn more

NatiVita Pharmaceutical Company has been developing innovative medications since 2012. Today, the company poses as an international research and manufacturing site drawing in state-of-the art innovative biotechnology solutions from many countries. The company has such partners in the technology field, as Biomed (Slovakia), Unipharma (Slovakia), Natco Pharma Ltd (India), Generium (Russia), Vitebsk State Medical University, Comenius University in Bratislava, in particular, the Jessenius Faculty of Medicine and Biomedical Center in Martin (Slovakia), Genetic Engineering and Biotechnology Center (Cuba).

NatiVita medications have been successfully registered on the domestic market and they have been actively used for cancer therapy. A number of new drugs are being developed at the moment; very soon, new medications will be on offer for treatment of patients with serious diseases.